• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

obesity - Articles and news items

O is for Obesity

Blog / 2 December 2016 / Niamh Louise Marriott, Digital Editor

O is for Obesity – the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest research…

Gelesis appoints new Chief Operating Officer in anticipation of obesity product launch

Industry news / 6 September 2016 / Niamh Louise Marriott, Digital Content Producer

Gelesis, a biotechnology company focused on developing products to safely induce weight loss and improve glycaemic control, have appointed David Pass, PhD as Chief Operating Officer…

Early response to Saxenda results in improvement in weight loss

Industry news / 3 June 2016 / Victoria White, Digital Content Producer

Three-year data show early response to Novo Nordisk’s Saxenda (liraglutide 3 mg) resulted in improvements in weight loss and cardiometabolic risk factors…

 

Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +